Tag: Ministry of Health Care

Russia has one of shortest periods for introducing foreign drugs onto the market

The recognition of foreign drug certificates in Russia should be based on the principles of reciprocity. This was announced by Elena Maksimkina, the Head of the Department of Drug Supply and Regulation of Medical Devices.

R-Pharm will supply Viekira Pak to Russian Ministry of Health

The Ministry of Health of the Russian Federation announced the results of the tender for supply of dasabuvir/ombitasvir/paritaprevir/ritonavir, a new drug for hepatitis C. As it was expected, the declared winner was R-Pharm.

49% of cancer drugs purchased by Russian Ministry were manufactured in Russia

According to IQVIA, in 2017, the Russian market of anti-tumor drugs was about 72 billion rubles in value terms and amounted to 14 million packages in physical terms.

Russian Ministry of Health proposes to introduce fines for inflating prices of VED

Sanctions will be imposed on pharmacists and drug manufacturers inflating prices of vital and essential drugs (VED). The Ministry of Health proposed to introduce fines for inflating prices of VED.

Russia may enact its register of interchangeable medicines from January 1, 2019

Russian Ministry of Health completed its work on the bill to amend the Federal Law “On Circulation of Medicines” which provides, in particular, for the establishment of a register of interchangeable drugs.

GSK will supply medicines worth 1.1 billion rubles to Russian Ministry of Health

Since the start of 2018, GlaxoSmithKline Trading CJSC, the Russian division of British GSK, has won five competitive bids to supply the drugs against HIV, hepatitis B, C and tuberculosis.

Nacimbio will supply blood plasma product to Russian Ministry of Health

The Russian Ministry of Health will purchase a blood plasma product from Nacimbio, a subsidiary of Rostec Corporation, for more than 1 billion rubles following two auctions held by the Ministry for supply of this medicine.

Russia approves Venclexta for the treatment of CLL

AbbVie announced that the Russian Ministry of Health approved Venclexta (venetoclax), a drug, for oral administration. The drug is a potent selective inhibitor of antiapoptotic protein of B-cell lymphoma.

Pharmaceutical manufacturers may be fined 5 million rubles for false information

pharma manufacturing
For incomplete or distorted provision of details, which caused harm to the life or health of citizens, the draft law establishes the administrative liability in the form of a fine ranging from one million to five million rubles.

Russian Ministry did not change its position regarding drug sales in retail stores

The Russian Minister of Health Veronika Skvortsova believes that the idea of selling drugs in retail stores is deliberately inflated by "certain interested parties."

WHO creates a high-level commission focused noncommunicable diseases

WHO announced a high-level commission, comprised of heads of state and ministers, leaders in health and development The group will propose innovative solutions to accelerate prevention and control of noncommunicable diseases.

Russia is preparing criminal code amendments for counterfeit products

The Russian Ministry of Health began to prepare a draft law on amendments to the Criminal Code of the Russian Federation in order to fight the circulation of falsified, counterfeit, substandard, and unregistered medicinal products.

Russia increases its budget for antiretroviral drugs by 20% in 2018

The Russian Ministry of Health wants to prevent disruptions in the supplies of antiretroviral drugs. This year, the budget of the Ministry allocated 21.6 billion rubles for this purpose.

Prices for medicines from VED List declined in Russia by 1.8% over the year

According to the officials of the Russian Ministry of Health, the medicines from VED List become less expensive as a result of government regulation and price monitoring in this category

Russia approves the mechanism for introducing the medicines into circulation

A draft federal law on the introduction of medicinal products for human use into civil circulation was prepared by the Russian Ministry of Health

Cardiome Pharma brings Aggrastat to Russian market

Cardiome Pharma announced that its affiliate Correvio has entered into an exclusive license and distribution agreement with ZAO Firma Euroservice